sulfobromophthalein has been researched along with desipramine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Kinne, A; Roth, S; Schweizer, U | 1 |
3 other study(ies) available for sulfobromophthalein and desipramine
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
The tricyclic antidepressant desipramine inhibits T3 import into primary neurons.
Topics: Amino Acid Transport Systems, Neutral; Animals; Antidepressive Agents, Tricyclic; Biological Transport; Cells, Cultured; Cerebral Cortex; Desipramine; Dogs; Humans; Mice; Monocarboxylic Acid Transporters; Neurons; Sulfobromophthalein; Symporters; Triiodothyronine | 2010 |